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Background: Phaeohyphomycosis refers to infections caused by phaeoid fungi that can have an aggressive course in 
normal hosts. Involvement of the central nervous system may occur with a generally poor outcome. 
Clinical report and literature review: We report a case of Bipolaris sp. brain abscess in an immunologically competent 
host. We also review all previous cases of cerebral phaeohyphomycosis in normal hosts reported in the literature to 
date. 
Conclusions: Central nervous system phaeohyphomycosis remains an unusual disease; however, its incidence has 
been increasing in recent years. The prognosis of this condition is still poor, despite medical and surgical interventions. 
Aggressive diagnostic approaches and careful interpretation of cultures might modify the natural history of this 
disease. 
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INTRODUCTION 
Phaeohyphomycosis refers to soft tissue and systemic 
infections caused by phaeoid fungi. These are unusual 
pathogens that can affect the central nervous system 
(CNS). These ubiquitous organisms have been isolated 
from soil, water, and air, and as plant parasites or 
saprophytic fungi.l” Several cases of phaeohypho- 
mycosis have been reported in the past, and its incidence 
may be increasing, particularly in immunocompromised 
patients;4 however, cases have also been reported in 
immunocompetent hosts. 5,6 We report a case of phaeo- 
hyphomycosis in an immunologically competent host 
whose lesion was a primary brain abscess caused by 
Bipolaris sp. We also review all previous cases of 
cerebral phaeohyphomycosis in normal hosts reported 
in the literature to date. 
REPORT OF CASE 
A previously healthy 2%year-old African-American 
male presented to John Sealy Hospital in Galveston on 
23 December 2001 with a 3-month history of progressive 
diplopia and right-eye ptosis. He visited several 
optometrists and tried different prescription glasses, 
with no improvement of symptoms. Two months prior to 
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admission, he also started complaining of left-sided 
tongue and lip numbness. He denied a history of trauma 
and fever. The patient was a Galveston resident, who 
worked at a local bank as a purchasing manager. He 
denied any history of travel or soil exposure. He 
reported no allergies and no history of sinus infection. 
On initial physical examination, the pupils were 
found to be anisocoric (right > left), but reactive to light. 
Despite the complaint of binocular diplopia, the 
extraocular muscles were intact; however, there was a 
mild ptosis on the right eye. No other cranial nerve 
abnormalities were noted, and results of sensory and 
motor examinations were unremarkable. The results of 
a complete blood cell count, serum chemistry tests and 
liver function tests were normal. Serology for human 
immunodeficiency virus was negative. A skin test for 
tuberculosis was non-reactive. 
The patient’s initial evaluation included magnetic 
resonance imaging (MRI) of the brain, which showed a 
5.5 cm by 4 cm mass located in the region of the 
posterior right basal ganglia and posterior temporal lobe 
with additional extension into the brainstem (Figure 1). 
The optic tracts were also involved. A computed 
tomography scan of the brain obtained at the same time 
showed enhancement of the mass after the adminis- 
tration of contrast material. Both studies included sinus 
windows that showed no evidence of acute or chronic 
sinus infection. Our initial impression according to this 
finding was an aggressive primary brain neoplastic 
lesion. The patient underwent a stereotactic brain 
biopsy, and the pathology was reported as negative for 
malignancy, with some inflammation and reactive gliosis. 
Cultures were not sent at that time. The procedure was 
complicated by an intracranial hemorrhage leading to 
an increase in the intracranial pressure and a significant 
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Figure 1. MRI of the brain (TZ-weighted), showing the 
5.5 cm by 4 cm mass located in the region of the posterior 
right basal ganglia and posterior temporal lobe with 
surrounding edema. 
deterioration in mental status. The patient became 
unresponsive and required mechanical ventilation. 
A second stereotactic brain biopsy was performed; 
the pathology report described fungal hyphae and 
necrotizing granulomatous inflammation with severe 
vascular wall necrosis. Hyphae were seen with variable 
diameters, often wide with right-angle branching, 
occasionally septated, and they were well observed with 
hematoxylin-eosin and melanin-specific Fontana-Mason 
stains (Figure 2). Tissue submitted for culture was sliced 
and placed in plates of inhibitory mold agar and brain 
heart infusion agar and incubated at 30°C. A brown 
mold grew in the plates after 5 days. The mold was then 
subcultured in potato dextrose agar and forced to 
sporulate. Occasional geniculate conidiophores with 
dark macroconidia produced in a sympodial pattern 
were observed microscopically, indicating that the 
organism was a Bipolaris sp. Species identification was 
not possible, due to the scarcity of the macroconidia. 
Curiously, a sputum culture done immediately after the 
first biopsy also grew a Bipolaris sp., which was initially 
thought to be a contaminant. The patient was treated 
with itraconazole and amphotericin B; this was later 
changed to liposomal amphotericin B, due to nephro- 
toxicity. Voriconazole was tried but discontinued, 
secondary to hepatotoxicity, and itraconazole was 
resumed. Excision of the abscess was not feasible, due to 
its location. The patient’s response to therapy was poor, 
and after prolonged hospitalization complicated by 
ventilator-associated pneumonia and catheter-related 
infections, the patient died. An autopsy was not 
performed. 
DISCUSSION 
Phaeohyphomycosis is caused by several species of fungi 
(more than 100) that have in common the morphologic 
characteristic of a darkly pigmented melanin-containing 
cell wall that can be seen in unstained tissue or with 
routine hematoxylin-eosin stain.4%5 They have distinctive 
branched septated hyphae, but the definitive identific- 
ation is based on culture and characteristic microscopic 
features. Melanin has been implicated as an important 
factor in the pathogenesis of these infections, due to the 
protection it confers against phagocytosis4 Reports of 
these infections are complicated by several previous 
changes in taxonomy;5 nevertheless, we have attempted 
to use the most recent nomenclature available. 
We searched the MEDLINE database from 1966 
through April 2002, using the following terms: phaeo- 
hyphomycosis, brain abscess, CNS abscess, and immuno- 
competent. Additional cases were obtained from the 
bibliographies of these articles. In addition to our case, 
we found 20 cases of CNS involvement in immuno- 
competent hosts (Table 1). In these cases, diagnosis was 
confirmed by histopathology and cultures of tissue 
sample obtained by biopsy, excision of tissue or post- 
mortem examination (from brain tissue or, in cases of 
disseminated disease, from the major organ affected). 
The agents of phaeohyphomycosis have a worldwide 
distribution, and cases of CNS involvement have been 
reported in North America,r South America6 and 
Asia.3,5,7-9 Some species, such as Ramichloridium 
mackenziei, appear to be geographically restricted.7 
Most cases have been reported during the past 20 years 
(16 of 21 cases), and the most frequent causative agents 
were Cladophialophora bantiana (six cases), Bipolaris 
spicifera (three cases), Ramichloridium mackenziei 
(three cases), Curvularia lunata (two cases) and 
Wangiella dermatitides (two cases). The higher incidence 
of CNS involvement in some species might be related to 
differences in neurotrophism. This fact has been 
corroborated in mice animal models showing that 
species such as Cladophialophora bantiana are highly 
neurotropic1,3~6 and others, such as Bipolaris spicifera, 
are not.2 
In our review, most cases occurred in young people 
under the age of 35 years (12 cases), and there was a 
predilection for the male sex (12 cases). While it is well 
known for these fungi to cause disseminated disease in 
immunocompromised hosts, most of our cases had only 
CNS involvement (13 cases). This can be a distinctive 
feature of patients with apparently normal immunity. 
The varied presentations were single or multiple, 
uniloculated or multiloculated brain abscesses and 
diffuse granulomatous encephalitis (21 cases). Isolated 
meningeal involvement was not seen in these cases, but 
it has been reported before in immunocompromised 
patients.lO The histopathology usually showed granulo- 
matous inflammation around characteristic fungal 
elements (chlamydospores and/or septated hyphae).2 
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Figure 2. Hematoxylin-eosin stain of brain tissue showing hyphae with occasional swollen walls and branching (A). Multinucleated 
giant cells and polymorphonuclear cells as well as nuclear debris in association with the hyphae were prominent in some areas (B). 
Fontana-Mason staining revealed that the hyphae had melanin (C). Brown hyphae with conidia originating from geniculate 
conidiophore (D), 
Vascular wall necrosis can be a prominent feature and 
makes the prognosis very unfavorable, as for the patient 
reported here. 
The mechanism of CNS involvement has been 
proposed to be direct extension from a sinus infection or 
by fungemia.ll The fact that many of these patients have 
multiple brain abscesses and disseminated disease 
supports a hematogenous route of spread as being most 
common. The paranasal sinuses or the lung are the 
probable sources of fungemia.3J1 It is interesting to note 
that, from our review, only one patient had evidence of 
sinusitis, and three patients had concomitant lung 
involvement at the time of diagnosis. It is also relevant 
that, in the case we report today, the fungus was 
recovered from the sputum, despite a negative chest X- 
ray at the time of culture. These facts suggest that the 
initial phase of sinus and lung involvement is usually 
asymptomatic and clinically silent. Other sources of 
fungemia might also be related to trauma,ll cutaneous 
infection3 or illicit intravenous drug use.‘j 
Several therapeutic approaches have been used for 
these pathogens, with disappointing results. In our 
review, six patients survived after treatment, and in five 
of these, treatment included amphotericin B alone or in 
combination with flucytosine, different azoles and 
surgery. Resistance of these organisms to amphotericin 
B and different azoles has been reported, and is almost 
universal to flucytosine.ll-l3 Azoles as monotherapy 
have been rarely used (two cases in this review), but 
previous reports suggest that itraconazole and the new 
azoles such as voriconazole might have good activity 
even as single agents.4 In vitro data have shown that the 
recently FDA-approved voriconazole and other related 
drugs such as pozaconazole have comparable geometric 
mean MICs to itraconazole and amphotericin B.14 In 
contrast to itraconazole, voriconazole has excellent oral 
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Table 1. Cases of phaeohycomycosis of the central nervous system in normal hosts reported from 1966 to 2002 
Reference Year Species isolated Age Sex Site of disease Therapy Outcome 
2002 Bipolar-is sp. 28 M 
7 1998 Ramichloridium mackenziei 70 M 
7 1998 Ramichloridium mackenziei 70 M 
7 1998 Ramichloridium mackenziei 55 F 
6 1997 Cladophialophora bantiana 33 M 
15 1995 Cladophialophora bantiana” NR NR 
5 1993 Cladophialophora bantianaa 14 F 
11 1992 Bipolaris spicifera 26 F 
1 1992 Cladophialophora bantianaa 76 M 
8 1989 Cladophialophora bantianab 28 M 
9 1988 Fonsecaea predosoi 70 M 
10 1987 Cladophialophora ~pp.~ 55 F 
12 1986 
17 1985 
13 1984 
4 1983 
2 1981 Bipolaris spiciferad 21 F 
3 1980 Cladophialophora bantiana’ 17 F 
17 1979 Curvularia luna ta 25 M 
4 1977 
4 1966 
Bipolaris hawaiiensis 
Curvularia lunata 
Bipolaris spicifera 
Wangiella dermatitidis 
Curvularia pallescens 
Wangiella dermatitidis 
18 M 
41 M 
NR NR 
24 M 
13 M 
19 F 
Brain, sputum AMB, Lipid AMB ,Itra, Vori 
Brain AMB, 5-FC 
Brain AMB 
Brain AMB, 5-FC, Ket 
Brain AMB, Flu, 5-FC, Mic 
Brain 5-FC, Itra, surgery 
Brain Flu, surgery 
Died 
Unknown 
Died 
Died 
Died 
Survived 
Partial response, 
died 
Survived 
Died 
Survived 
No response 
Partial response, 
died 
Survived 
Survived 
Brain, sinuses 
Brain 
Brain 
Brain 
Brain, lung 
Brain 
Brain, lung 
Brain, 
osteomyelitis 
Brain, LN, bile 
Brain 
Brain 
Brain, spine, 
pleura, skin 
Brain,lung 
Brain, LN, liver, 
pancreas 
AMB, Ket 
AMB, 5-FC, surgery 
AMB 
AMB, 5-FC 
AMB, 5-FC, Ket, surgery 
AMB, 5-FC, surgery 
AMB 
NR 
AMB, Flu, 5-FC, Mic 
AMB, 5-FC 
AMB, surgery 
NR 
Partial response, 
died 
Survived 
Died 
AMB, 5-FC, Mic 
Mic 
Partial response 
(relapse) 
Partial response, 
died 
AMB Died 
AMB, amphotericin; Lipid AMB, lipid formulation of amphotericin B; Itra, itraconazole; Vori, voriconazole; 5-FC, flucytosine; Flu, 
fluconazole; Mic, miconazole; Ket, ketoconazole; NR, no record available; CSF, cerebrospinal fluid; LN, lymph node. 
“Reported as Xylohypha bantiana. 
bReported as Cladosporium trichoides. 
CReported as Cladosporium sp. 
dReported as Drechslera spicifera. 
‘Reported as Cladosporium bantianum. 
bioavailability and could be a good therapeutic alter- 
native for the treatment of this fungus, which usually 
requires prolonged therapy. Caspofungin and the related 
drug anidulafungin are at least 10 times less active in 
vitro than itraconazole and voriconazole against this 
mold.14 The clinical efficacies of all these new 
therapeutic agents will most likely be determined case 
by case in the future, due to the extremely low incidence 
of this fungal infection. To our knowledge, the patient we 
reported in this article was the first one treated with 
voriconazole for this condition. Unfortunately, therapy 
had to be discontinued early in the course of treatment, 
due to liver toxicity. It was proposed that the most 
effective treatment is complete or partial removal of the 
abscess by surgery;12J-l7 however, in our review, of six 
craniotomies that were performed, only two patients 
had good responses. 
The prognosis of this disease is poor, and the out- 
come in most cases is death.3 Among these 21 patients, 
the overall mortality was very high (11 cases). This 
number may be even higher, since four patients did not 
have adequate follow-up (two of them with initial 
incomplete response). Some patients had an initial 
partial response with subsequent progression or relapse 
of disease. It has been reported that the overall mortality 
of patients with phaeohyphomycosis is 79%, with a non- 
statistically significant difference between immuno- 
compromised and immunocompetent hosts.4 This might 
be explained by the fact that some of these isolates are 
resistant to amphotericin B, which has long been con- 
sidered the gold standard for empirical and definitive 
therapy.4 Furthermore, some of these competent patients 
might also have unrecognized immune dysfunction.3J1 
The incidence of phaeohyphomycosis appears to be 
increasing over time. This is understandable in the 
immunocompromised population, and may be due to 
the increasing number of transplant patients, more 
aggressive chemotherapies and the AIDS epidemic.4 
However, as we have shown in this review, this trend is 
also true for immunocompetent patients with CNS 
involvement. Increased awareness of this disease and 
improved isolation and identification techniques of 
laboratories may partly explain this. 
Because of the aggressive nature of this disease and 
the increased number of cases being reported, this 
review emphasizes that, although the majority of isolates 
from clinical laboratories reflect surface contamination 
or colonization,13 no isolate should be dismissed as such 
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based solely upon its reputation or the immuno- 
competent state of the host. Aggressive diagnostic 
approaches and careful interpretation of cultures might 
help to improve the natural history of this disease, which 
otherwise is invariably fatal. 
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